Technical Analysis for CDNA - CareDx, Inc.

Grade Last Price % Change Price Change
grade D 23.89 0.42% 0.10
CDNA closed up 0.42 percent on Thursday, January 17, 2019, on 88 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical CDNA trend table...

Date Alert Name Type % Chg
Jan 17 20 DMA Resistance Bearish 0.00%
Jan 17 Narrow Range Bar Range Contraction 0.00%
Jan 17 NR7 Range Contraction 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Up 3 Days in a Row Strength 0.00%
Jan 16 20 DMA Resistance Bearish 0.42%
Jan 16 MACD Bearish Signal Line Cross Bearish 0.42%
Jan 16 Wide Bands Range Expansion 0.42%
Jan 15 Calm After Storm Range Contraction 2.14%
Jan 15 NR7 Range Contraction 2.14%

Older signals for CDNA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, California.
Is CDNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 30.8
52 Week Low 5.07
Average Volume 770,560
200-Day Moving Average 19.0567
50-Day Moving Average 25.9818
20-Day Moving Average 23.929
10-Day Moving Average 24.923
Average True Range 2.1547
ADX 12.3
+DI 20.9002
-DI 26.4623
Chandelier Exit (Long, 3 ATRs ) 21.2459
Chandelier Exit (Short, 3 ATRs ) 25.5741
Upper Bollinger Band 27.8262
Lower Bollinger Band 20.0318
Percent B (%b) 0.49
BandWidth 32.573029
MACD Line -0.4279
MACD Signal Line -0.4072
MACD Histogram -0.0207
Fundamentals Value
Market Cap 538.5 Million
Num Shares 22.5 Million
EPS -1.39
Price-to-Earnings (P/E) Ratio -17.19
Price-to-Sales 2.74
Price-to-Book 10.33
PEG Ratio -0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.50
Resistance 3 (R3) 25.39 24.76 25.23
Resistance 2 (R2) 24.76 24.35 24.81 25.14
Resistance 1 (R1) 24.32 24.10 24.54 24.43 25.05
Pivot Point 23.69 23.69 23.80 23.74 23.69
Support 1 (S1) 23.25 23.28 23.47 23.36 22.73
Support 2 (S2) 22.62 23.03 22.67 22.64
Support 3 (S3) 22.18 22.62 22.55
Support 4 (S4) 22.29